Activation of Biobank Registry for Bilio-pancreatic Diseases

Launched by IRCCS SAN RAFFAELE · Aug 12, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the causes of certain pancreatic diseases, including pancreatitis and pancreatic cancer. Researchers are creating a biobank, which is a collection of biological samples and health information from participants. This biobank will help them study how both genetics (inherited traits) and environmental factors (like lifestyle or exposure to certain substances) may work together to influence the development of these diseases. By identifying different risk factors, they hope to improve prevention and early diagnosis of these conditions.

To participate in this trial, individuals must be at least 18 years old and willing to provide informed consent, which means they agree to take part in the study after understanding what it involves. The trial is open to all genders, and it is currently recruiting participants. Those who join can expect to provide samples and health information that will contribute to important research that could lead to better understanding and treatment of pancreatic diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age \>= 18 years
• • signed informed consent
• Exclusion Criteria:
• • age \< 18 years
• • unwilling to sign informed consent